Encore Vision Inc.
Developer of therapeutic solutions and technologies for the treatment of presbyopia.
Launch date
Market cap
-
Enterprise valuation
€23m (Public information from May 2016)
Spokane Washington (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$5.0m | Early VC | ||
N/A | $2.5m | Early VC | |
N/A | $4.5m Valuation: $25.0m | Early VC | |
N/A | Acquisition | ||
Total Funding | €10.9m |